These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 5786524)
21. Advertising prescription drugs direct to the public. What are the issues? Hoff LC Vital Speeches Day; 1984 Jul; 50(18):573-6. PubMed ID: 10267118 [No Abstract] [Full Text] [Related]
22. The economic wisdom of regulating pharmaceutical "freebies". Fisher SH Duke Law J; 1991 Feb; (1):206-39. PubMed ID: 10114416 [No Abstract] [Full Text] [Related]
24. Direct mail promotion. BOYER F Bull N Y Acad Med; 1962 Mar; 38(3):207-12. PubMed ID: 13872180 [No Abstract] [Full Text] [Related]
25. [Letter: Advertising for Ponderal]. Persson I Ugeskr Laeger; 1973 Nov; 135(45):2471. PubMed ID: 4773734 [No Abstract] [Full Text] [Related]
26. [Critical reflections on the concept "drug advertising" regarding the marketing of the drug Ponderal (fenfluramine)]. Schjott F Ugeskr Laeger; 1973 Sep; 135(36):1958-61. PubMed ID: 4774003 [No Abstract] [Full Text] [Related]
27. Rules of conduct and the pharmaceutical industry. Cox P Lancet; 1984 Mar; 1(8375):517. PubMed ID: 6142245 [No Abstract] [Full Text] [Related]
29. [Industry has almost monopoly on information]. Lie A Nord Med; 1976 Jun; 91(6-7-1):194. PubMed ID: 934797 [No Abstract] [Full Text] [Related]
30. The party's over. No more pharmaceutical freebies. Burke EC Minn Med; 1991 Mar; 74(3):5-6. PubMed ID: 2030682 [No Abstract] [Full Text] [Related]
31. Pharmaceutical promotions. Frumin M; Komaromy M; O'Shea JD N Engl J Med; 1992 Dec; 327(23):1687; author reply 1688. PubMed ID: 1435908 [No Abstract] [Full Text] [Related]
32. Rules of conduct and the pharmaceutical industry. Collier J Lancet; 1984 Feb; 1(8374):453. PubMed ID: 6142179 [No Abstract] [Full Text] [Related]
33. Excess marks the spot: the FDA blows the whistle on abuses in new-drug ads. Time; 1982 Sep; 120(13):83. PubMed ID: 10257313 [No Abstract] [Full Text] [Related]
34. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan. Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008 [TBL] [Abstract][Full Text] [Related]
35. The pharmaceutical industry--to whom is it accountable? Holmer AF N Engl J Med; 2000 Nov; 343(19):1415; discussion 1417. PubMed ID: 11183877 [No Abstract] [Full Text] [Related]
36. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages. Consum Rep; 2003 Feb; 68(2):33-7. PubMed ID: 12516586 [No Abstract] [Full Text] [Related]
37. Advertisements. FDA orders Abbott to change misleading ads for Norvir. AIDS Policy Law; 2004 Jul; 19(12):9. PubMed ID: 15282864 [No Abstract] [Full Text] [Related]
38. US aims to tighten rules on direct-to-consumer drug ads. Vastag B Nat Biotechnol; 2007 Mar; 25(3):267. PubMed ID: 17344868 [No Abstract] [Full Text] [Related]
39. [Can physicians rely upon the drug information?]. Hansson O Nord Med; 1976 Jun; 91(6-7-1):193. PubMed ID: 934796 [No Abstract] [Full Text] [Related]
40. Unsolicited fluoxetine mailing triggers investigation in USA. Larkin M Lancet; 2002 Jul; 360(9328):234. PubMed ID: 12133668 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]